Characterization of solvatomorphs of methotrexate using thermoanalytical and other techniques

Acta Pharmaceutica

Volumn 59, Issue 3, 2009, Pages 245-257

  Chadha, Renu ^a   Arora, Poonam ^a   Kaur, Rupinder ^a   Saini, Anupam ^a   Singla, Madan Lal ^b   Jain, Dharamvir Singh ^c  

^a PANJAB UNIVERSITY   (India)

^b CSIR CENTRAL SCIENTIFIC INSTRUMENTS ORGANISATION   (India)

^c PANJAB UNIVERSITY   (India)

Author keywords

Desolvation; Dissolution rate; Enthalpy of solution; Methotrexate; Pseudopolymorph; Solution calorimetry; Solvatomorph

Indexed keywords

METHOTREXATE; SOLVENT;

ANALYTIC METHOD; ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; ENTHALPY; MOLECULE; THERMOGRAVIMETRY; X RAY POWDER DIFFRACTION;

EID: 70350120306     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-009-0024-9     Document Type: Article

References (25)

1. M. C. Tros de Ilarduya, C. Martin, M. M. Goni and M. C. Martinez-Oharriz, Polymorphism of sulindac: Isolation and characterization of a new polymorph and three new solvates, J. Pharm. Sci. 86 (1997) 248-251; DOI: 10.1021/js9601748. (Pubitemid 27078393)
2. H. G. Brittain, Polymorphism and solvatomorphism 2005, J. Pharm. Sci. 96 (2007) 705-760; DOI: 10.1002/jps.20772. (Pubitemid 46657863)
3. M. R. Yadav, A. R. Shaikh, V. Ganesan, R. Giridhar and R. Chadha, Studies on the crystal forms of pefloxacin: Preparation, characterization and dissolution profile, J. Pharm. Sci. 97 (2007) 2637-2648; DOI: 10.1002/jps.21178.
4. E. Swanepoel, W. Liebenberg and M. M. de Villiers, Quality evaluation of generic drugs by dissolution test: changing the USP dissolution medium to distinguish between active and non-active mebendazole polymorphs, Eur. J. Pharm. Biopharm. 55 (2003) 345-349; DOI: 10.1016/S0939- -6411(03)00004-13
5. S. Ghodbane and J. A. McCauley, Study of polymorphism of 3-((3-(2-(7-chloro-2-quinolinyl)-( E)-ethenyl)phenyl)((3-(dimethylamino-3- oxopropyl)thio)methyl)-thio) propanoic acid (MK571) by DSC, TG, XRPD and solubility measurements, Int. J. Pharm. 59 (1990) 281-286; DOI: 10.1016/0378-5173(90)90119-O. (Pubitemid 20146160)
6. D. Giron, C. Goldbronn, M. Mutz, S. Pfeffer, P. Piechon and P. Schwab, Solid state characterizations of pharmaceutical hydrates, J. Therm. Anal. 68 (2002) 453-465.
7. B. K. Saha, A. Nangia and M. Jaskolski, Crystal engineering with hydrogen bonds and halogen bonds, Cryst. Eng. Comm. 7 (2005) 355-358; DOI: 10.1039/b501693b. (Pubitemid 41396881)
8. Martindale, The Complete Drug Reference, 34th ed., Pharmaceutical Press, London 2005, p. 553.
9. H. K. Chan and I. Gonda, Methotrexate: Existence of different types of solid, Int. J. Pharm. 68 (1991) 179-190.
10. K. Urakami, Characterization of pharmaceutical polymorphs by isothermal calorimetry, Curr. Pharm. Biotech. 6 (2005) 193-203; DOI: 10.2174/ 1389201054022904. (Pubitemid 40933055)
11. H. G. Brittain, Spectral methods for the characterization of polymorphs and solvates, J. Pharm. Sci. 86 (1997) 405-412; DOI: 10.1021/js960238e. (Pubitemid 27154753)
12. D. Giron, Investigations of polymorphism and pseudo-polymorphism in pharmaceuticals by combined thermoanalytical techniques, J. Therm. Anal. 64 (2001) 37-60.
13. J. Bauer, J. Morley, S. Spanton, F. J. J. Leusen, R. Henry, S. Hollis, W. Heitmann, A. Mannino, J. Quick and W. Dziki, Identification, preparation and characterization of several polymorphs and solvates of terazosin hydrochloride, J. Pharm. Sci. 95 (2006) 917-928.
14. G. W. Lu, M. Hawley, M. Smith, B. M. Geiger and W. Pfund, Characterization of a novel polymorphic form of celecoxib, J. Pharm. Sci. 95 (2006) 305-317; DOI: 10.1002/jps.20522. (Pubitemid 43241973)
15. A. Othman, J. S. O. Evans, I. R. Evans and R. K. Harris, Structural study of polymorphs and solvates of finasteride, J. Pharm. Sci. 96 (2007) 1380-1397; DOI: 10.1002/jps.20940. (Pubitemid 46797496)
16. M. R. Caira, G. Bettinetti, M. Sorrenti and L. Catenacci, Relationships between structural and thermal properties of anhydrous and solvated crystalline forms of brodimoprim, J. Pharm. Sci. 96 (2007) 996-1007; DOI: 10.1002/jps.20934. (Pubitemid 46797471)
17. M. Sheikhzadeh, S. Rohani, A. Jutan and T. Manifar, Quantitative and molecular analysis of buspirone hydrochloride polymorphs, J. Pharm. Sci. 96 (2007) 569-583; DOI: 10.1002/jps.20723. (Pubitemid 46466079)
18. G. D. Christian, Acid-base Equilibria, in Analytical Chemistry, 6th ed., John Wiley, Singapore 2004, pp. 253-254.
19. P. Balk and G. C. Benson, Calorimetric determination of the surface enthalpy of potassium chloride, J. Phys. Chem. 63 (1959) 1009-1012.
20. USP 27, NF 22, USP Convention Inc., Rockville (MD) 2004, pp. 2303-2304.
21. P. A. Sutton, V. Cody and G. D. Smith, Crystal structure of methotrexate tetrahydrate, J. Am. Chem. Soc. 108 (1986) 4155-4158; DOI: 10.1021/ja00274a051.
22. T. W. Hambley, H. K. Chan and I. Gonda, Crystal and molecular structure of methotrexate, J. Am. Chem. Soc. 108 (1986) 2103-2105; DOI: 10.1021/ja00268a068.
23. M. R. Caira, G. Bettinetti and M. Sorrenti, Structural relationships, thermal properties and physicochemical characterization of anhydrous and solvated crystalline forms of tetroxoprim, J. Pharm. Sci. 91 (2002) 467-481; DOI: 10.1002/jps.10034. (Pubitemid 34137368)
24. K. Terada, H. Kitano, Y. Yoshihashi and E. Yonemochi, Quantitative correlation between initial dissolution rate and heat of solution, Pharm. Res. 17 (2008) 920-924.
25. I. P. Dominic, B. S. Gerald, J. M. Stevenson, S. Lindenbaum, A. W. Douglas, S. D. Klein and J. A. McCauley, High resolution spectroscopic evidence and solution calorimetry studies on the polymorphs of enalapril maleate, Int. J. Pharm. 28 (1986) 183-191.